On September 1, 2019, GB Sciences, Inc. and Ksenia Griswold terminated their relationship wherein Ms. Griswold had been serving as an executive officer of the GB Sciences in the capacity of Chief Financial Officer and Chief Operating Officer. GB Sciences is appreciative of the contribution Ms. Griswold made to the Company and wishes her every success in the future. On September 5, 2019, the Board of Directors appointed Zach Swarts Interim Chief Financial Officer.

Mr. Swarts has served as the Company's director of finance and accounting since October 2017. Prior to his employment with the Company, he worked for Swarts & Swarts, CPAs as the manager of the forensic accounting and litigation support department from April 2016 to October 2017.